The Journal of Medical Microbiology, Vol 40, Issue 1 23-30, Copyright © 1994 by Society for General Microbiology

JOURNAL ARTICLE

Antibiotic-induced release of endotoxin from bacteria in vitro

H. A. Crosby, J. F. Bion, C. W. Penn and T. S. Elliott
Department of Clinical Microbiology, Queen Elizabeth Hospital, Birmingham.

The ability of cefotaxime, ciprofloxacin, piperacillin and tobramycin to cause release of endotoxin was examined in vitro with cultures of Enterobacter cloacae and Escherichia coli. Endotoxin was measured by a quantitative limulus amoebocyte lysate assay and its presence was confirmed by silver staining of the lipopolysaccharide moiety following SDS-PAGE. The morphology of the bacteria during antibiotic exposure was examined by scanning electronmicroscopy. Cefotaxime, ciprofloxacin and piperacillin caused significant endotoxin release, correlating with their ability to affect cell-wall morphology, causing filamentation, wall breakage and cell lysis. In contrast, little endotoxin was released when bacteria were exposed to tobramycin and no morphological changes were observed when bacteria were exposed to bactericidal concentrations of this aminoglycoside. Its antimicrobial spectrum and bactericidal activity make tobramycin an appropriate agent for treatment of sepsis caused by gram-negative bacteria and its lack of propensity to elicit excessive release of endotoxin may avoid exacerbation of endotoxin-related shock in sepsis.

This article has been cited by other articles:

				G. Goscinski, E. Tano, E. Lowdin, and J. Sjolin Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: higher release after the second dose J. Antimicrob. Chemother., August 1, 2007; 60(2): 328 - 333. [Abstract] [Full Text] [PDF]

				P. Lake, J. DeLeo, F. Cerasoli, L. Logdberg, M. Weetall, and D. Handley Pharmacodynamic Evaluation of the Neutralization of Endotoxin by PMX622 in Mice Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2987 - 2992. [Abstract] [Full Text] [PDF]

				E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]

				B. Zhao, R. A. Bowden, S. A. Stavchansky, and P. D. Bowman Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1587 - C1595. [Abstract] [Full Text] [PDF]

				K. Lewis Programmed Death in Bacteria Microbiol. Mol. Biol. Rev., September 1, 2000; 64(3): 503 - 514. [Abstract] [Full Text] [PDF]

				P. C. Braga, M. T. Sala, and M. dal Sasso Pharmacodynamic Effects of Subinhibitory Concentrations of Rufloxacin on Bacterial Virulence Factors Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1013 - 1019. [Abstract] [Full Text]

				W. R. Byrne, S. L. Welkos, M. L. Pitt, K. J. Davis, R. P. Brueckner, J. W. Ezzell, G. O. Nelson, J. R. Vaccaro, L. C. Battersby, and A. M. Friedlander Antibiotic Treatment of Experimental Pneumonic Plague in Mice Antimicrob. Agents Chemother., March 1, 1998; 42(3): 675 - 681. [Abstract] [Full Text]

				D.P. Healy, C.E. Clendening, A.N. Neely, and I.A. Holder Antibiotic-induced endotoxin release is organism-dependent in experimental Gram-negative sepsis Innate Immunity, October 1, 1997; 4(5): 315 - 323. [Abstract] [PDF]

				D. P. Healy, C. L. Verst-Brasch, C. E. Clendening, A. N. Neely, and I. A. Holder Influence of drug class and dose size on antibiotic-induced endotoxin/IL-6 release and impact on efficacy of anti-endotoxin antibody Innate Immunity, June 1, 1996; 3(3): 219 - 227. [Abstract] [PDF]

				R.G. Holzheimer, J.F. Hirte, B. Reith, W. Engelhardt, K.H. Horak, R. Leppert, A. Aasen, P. Capel, R. Urbaschek, H. Karch, et al. Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients Innate Immunity, June 1, 1996; 3(3): 261 - 267. [Abstract] [PDF]

				D. P. Healy, C. L. Verst-Brasch, C. E. Clendening, A. N. Neely, and I. A. Holder Kinetics of endotoxin and interleukin-6 following multiple doses of antibiotics for experimental Gram-negative bacterial sepsis Innate Immunity, April 1, 1996; 3(2): 93 - 101. [PDF]

				W. Christ, O Asano, A. Robidoux, M Perez, Y Wang, G. Dubuc, W. Gavin, L. Hawkins, P. McGuinness, M. Mullarkey, et al. E5531, a pure endotoxin antagonist of high potency Science, April 7, 1995; 268(5207): 80 - 83. [Abstract] [PDF]